Contact this trialFirst, we need to learn more about you.
Antiretroviral Therapy
Combination Antiretroviral Therapy for Primary Biliary Cholangitis
Recruiting0 awardsPhase 2
Montréal, Quebec
This trial is testing a new combination therapy for primary biliary cholangitis (PBC) patients who have not responded to Ursodeoxycholic Acid (UDCA). The trial will compare the new therapy to a placebo, and all patients will be offered the new therapy after the trial is completed.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.